The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 4, 2009, Pages 392.e1-392.e5

  Gyamfi, Cynthia ^a   Horton, Amanda L ^b   Momirova, Valerija ^c   Rouse, Dwight J ^d   Caritis, Steve N ^e   Peaceman, Alan M ^f   Sciscione, Anthony ^g   Meis, Paul J ^h   Spong, Catherine Y ⁱ   Dombrowski, Mitchell ^j   Sibai, Baha ^k   Varner, Michael W ^l   Iams, Jay D ^m   Mercer, Brian M ⁿ   Carpenter, Marshall W ^o   Lo, Julie ^p   Ramin, Susan M ^q   O'Sullivan, Mary Jo ^r   Miodovnik, Menachem ^s   Conway, Deborah ^t  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k BROWN UNIVERSITY   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

ⁿ WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^o UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^p UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^r Mays Cancer Center at UT Health San Antonio   (United States)

^s GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^t EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

17 hydroxy progesterone caproate; gestational diabetes; singletons; twins

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; RISK ASSESSMENT; SECONDARY ANALYSIS; TWIN PREGNANCY;

EID: 70349308198     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.06.036     Document Type: Article

References (17)

1. Mattison D.R., Damus K., Fiore E., Petrini J., and Alter C. Preterm delivery: a public health perspective. Paediatr Perinat Epidemiol 15 Suppl 2 (2001) 7-16
2. Creasy R.K. Preterm birth prevention: where are we?. Am J Obstet Gynecol 168 (1993) 1223-1230
3. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
4. da Fonseca E.B., Bittar R.E., Carvalho M.H., and Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 (2003) 419-424
5. American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 419: use of progesterone to prevent preterm birth. Obstet Gynecol 112 (2008) 963-965
6. Branisteanu D.D., and Mathieu C. Progesterone in gestational diabetes mellitus: guilty or not guilty?. Trends Endocrinol Metab 14 (2003) 54-56
7. Picard F., Wanatabe M., Schoonjans K., Lydon J., O'Malley B.W., and Auwerx J. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation. Proc Natl Acad Sci U S A 99 (2002) 15644-15648
8. Rebarber A., Istwan N.B., Russo-Stieglitz K., et al. Increased incidence of gestational diabetes in women receiving prophylactic 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Diabetes Care 30 (2007) 2277-2280
9. Kjos S.L., and Buchanan T.A. Gestational diabetes mellitus. N Engl J Med 341 (1999) 1749-1756
10. Buhling K.J., Henrich W., Starr E., et al. Risk for gestational diabetes and hypertension for women with twin pregnancy compared to singleton pregnancy. Arch Gynecol Obstet 269 (2003) 33-36
11. Rouse D.J., Caritis S.N., Peaceman A.M., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 357 (2007) 454-461
12. American College of Obstetricians and Gynecologists. ACOG Committee practice bulletin number 30: gestational diabetes. Obstet Gynecol 93 (2001) 525-538
13. Margolies K.L., Bonds D.E., Rodabough R.H., et al. Effect of oestrogen plus progestin on the incidence of diabetes on postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47 (2004) 1175-1187
14. Ordonez P., Moreno M., Alonso A., Llaneza P., Diaz F., and Gonzalez C. 17 beta-estradiol and/or progesterone protect from insulin resistance in STZ-induced diabetic rats. J Steroid Biochem Mol Biol 111 (2008) 287-294
15. Spong C.Y. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 110 (2007) 405-415
16. Fonseca E.B., Celik E., Parra M., Singh M., Nicolaides K.H., and Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357 (2007) 462-469
17. DeFranco E.A., O'Brien J.M., Adair C.D., et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 30 (2007) 697-705